UK Wants Early Access Scheme To Remain ‘Relevant And Attractive’ Following Brexit
Proposals Aim To Reduce Burden Associated With Collecting Real-World Data
The MHRA has drawn up measures to improve regulatory certainty around the UK’s early patient access scheme while reducing regulatory burden in certain areas of its operation.
